The customer observed falsely elevated alinity i free t4 results for a 84 year old male patient.The patient was previously diagnosed with hypothyroidism in (b)(6) 2022 and was started on the medication thyradin.The following information was provided (customer provided reference ranges: free t4 is 0.70 to 1.48 ng/dl, tsh is 0.35 to 4.94 uiu/ml): (b)(6) 2024: free t4 = 2.66 ng/dl, repeat at another laboratory generated results within the normal range, free t3 = 2.51, tsh = 6.22 uiu/ml.(b)(6) 2024 sid (b)(6) : free t4 = 1.27 ng/dl, repeat = 0.86 ng/dl.Free t3 = 2.27, repeat = 2.12.Tsh = 4.93 uiu/ml, repeat = 6.08 uiu/ml.Patient history (cardiovascular examinations with chf, hypertension, and ischemic heart disease) and historical results: (b)(6) 2022: tsh = 20.23 uiu/ml, free t4 = 0.84 ng/dl, free t3 = 2.36.The patient was referred to the current department and diagnosed with hypothyroidism and started on thyradin 12.5 ug.(b)(6) 2022: the patient didn¿t have a repeat visit and the medication was discontinued.(b)(6) 2023: tsh = 6.88 uiu/ml, free t4 = 1.29 ng/dl.(b)(6) 2023: tsh = 16.34 uiu/ml, free t4 = 0.98 ng/dl.The patient was restarted on thyradin 12.5 ug.(b)(6) 2023: tsh = 16.37 uiu/ml, free t4 = 1.11 ng/dl.The thyradin was increased to 25 ug.(b)(6) 2023: tsh = 4.95 uiu/ml, free t4 = 1.36 ng/dl.(b)(6) 2023: tsh = 2.8 uiu/ml, free t4 = 1.68 ng/dl.The thyradin was reduced to 12.5/25 ug every other day.The customer is questioning the alinity i free t4 results generated on (b)(6) 2024 and (b)(6) 2024.The patient¿s medication has not changed due to the falsely elevated alinity i free t4 results.The customer is not questioning the alinity i tsh results.No impact to patient management was reported.
|